Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
39.20
-0.82 (-2.05%)
At close: Dec 5, 2025, 4:00 PM EST
39.25
+0.05 (0.13%)
After-hours: Dec 5, 2025, 7:59 PM EST
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 44.56, with a low estimate of 30 and a high estimate of 85. The average target predicts an increase of 13.67% from the current stock price of 39.20.
Analyst Consensus: Hold
* Price targets were last updated on Nov 4, 2025.
Analyst Ratings
The average analyst rating for Hims & Hers Health stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 7 | 7 | 8 | 8 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 11 | 11 | 11 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Sell Maintains $28 → $32 | Sell | Maintains | $28 → $32 | -18.37% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $85 | Strong Buy | Reiterates | $85 | +116.84% | Nov 4, 2025 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 21, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $68 | Strong Buy | Maintains | $68 | +73.47% | Sep 12, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $48 → $37 | Hold | Maintains | $48 → $37 | -5.61% | Aug 18, 2025 |
Financial Forecast
Revenue This Year
2.40B
from 1.48B
Increased by 62.21%
Revenue Next Year
2.85B
from 2.40B
Increased by 18.79%
EPS This Year
0.49
from 0.53
Decreased by -8.01%
EPS Next Year
0.66
from 0.49
Increased by 34.66%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.5B | 3.2B | ||||
| Avg | 2.4B | 2.8B | ||||
| Low | 2.3B | 2.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 68.6% | 32.2% | ||||
| Avg | 62.2% | 18.8% | ||||
| Low | 55.2% | 3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.61 | 1.44 | |
| Avg | 0.49 | 0.66 | |
| Low | 0.38 | 0.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 14.4% | 193.8% | |
| Avg | -8.0% | 34.7% | |
| Low | -28.2% | -70.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.